Peptide Synthesis Market To Reach $1,840.6 Million By 2033

Peptide Synthesis Market Growth & Trends

The global peptide synthesis market size is expected to reach USD 1,840.6 million by 2033, registering a CAGR of 7.71% from 2025 to 2033, according to a new report by Grand View Research, Inc. Significant research and innovation targeted towards the development of peptide therapeutics is set to boost the market growth in the near future. Additionally, increasing advancements in the peptide synthesis technologies is expected to offer profitable opportunities for the companies operating in the market.

A surge in the demand for custom peptide synthesis has been observed in the recent years; several companies operating in this industry offer products and services associated with custom peptide synthesis. For instance, a UK based company namely, Almac Group offers peptide synthesis suitable for research use. Constantly growing demand and evolving market landscape for custom peptides is set to offer lucrative opportunities for the market growth. The suppliers are expanding their production capacity to suffice the increasing demand for high quality peptides across research and therapeutics areas.

Rising focus of the pharmaceutical companies towards the development of novel biologics and shifting the peptide drugs from the pipeline stage to commercial scale further strengthens the market growth. Increase in the number of research activities performed on exploring the potential of high-quality peptides and peptide libraries in the development of vaccines and biomarker discovery heavily contributes to the revenue generated by the global peptide synthesis market. Moreover, introduction of modified peptides (GMP peptides) that possess enhanced stability and pharmacokinetic properties in the market is expected to maintain the double-digit market growth throughout the forecast period.

Therapeutic peptide development has witnessed remarkable growth in the recent years, this is further driven by significant increase in the patient pool suffering from cardiovascular and metabolic diseases. This has propelled the discovery of bioactive peptides exponentially which further drives the market demand.

 Request a free sample copy or view report summary: Peptide Synthesis Market Report

Peptide Synthesis Market Report Highlights

• The reagents and consumables in the product segment dominated the peptide synthesis market with a revenue share of 47.97% in 2024. The equipment segment is expected to register a significant CAGR during the forecast period.

• The technology segment's liquid phase peptide synthesis (LPPS) dominated the peptide synthesis market with a revenue share of 44.04% in 2024. The hybrid technology segment in the peptide synthesis market is expected to register the fastest CAGR during the forecast period

• Therapeutics dominated the market with a revenue share of 70.35% in 2024. The diagnosis application segment in the peptide synthesis market is expected to register the fastest CAGR during the forecast period.

• Pharmaceutical and biotechnology companies led the market with a revenue share of 66.74% in 2024. The Contract Development & Manufacturing Organization & Contract Research Organization (CDMOs & CROs) in the end-use segment in the peptide synthesis industry are expected to register the fastest CAGR during the forecast period.

• North America peptide synthesis dominated the global market with the largest revenue share of 38.95% in 2024. The peptide synthesis market in Asia Pacific is expected to register the fastest growth, with a CAGR of 9.33% during the forecast period. 

Peptide Synthesis Market Segmentation

Grand View Research has segmented global peptide synthesis market report based on product, technology, application, end-use, and region:

Peptide Synthesis Product Outlook (Revenue, USD Million, 2021 - 2033)

• Equipment

  • Peptide Synthesizers

  • Lyophilizers

  • Chromatography Equipment

  • Others

• Reagents & Consumables

  • Resins

  • Amino Acids

  • Coupling Reagents

  • Dyes & Fluorescent Labeling Reagents

  • Others

• Services

Peptide Synthesis Technology Outlook (Revenue, USD Million, 2021 - 2033)

• Solid Phase Peptide Synthesis (SPPS)

• Liquid Phase Peptide Synthesis (LPPS)

• Hybrid Technology

Peptide Synthesis Application Outlook (Revenue, USD Million, 2021 - 2033)

• Therapeutics

  • Cancer

  • Metabolic

  • Cardiovascular Disorder

  • Respiratory

  • GIT (Gastrointestinal Disorders)

  • Infectious Diseases

  • Pain

  • Dermatology

  • CNS

  • Renal

  • Others

• Diagnosis

• Research

Peptide Synthesis End-use Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceutical & Biotechnology Companies

• CDMOs & CROs

• Academic & Research Institutes

Peptide Synthesis Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Peptide Synthesis Market

• Thermo Fisher Scientific Inc.

• Merck KGaA

• GenScript

• Bachem Holding AG

• Biotage

• Creative Diagnostics

• PolyPeptide Group

• Syngene International Limited

• Puresynth Research Chemicals Pvt Ltd.

• Lonza